Trial Profile
A Randomized, Open-Label Study to Assess the Pain, Toxicity, and Quality of Life Effects of Adding Venlafaxine to the Pain Management Regimen for Patients Treated With Chemoradiation for Head and Neck Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary) ; Methadone (Primary) ; Oxycodone (Primary) ; Venlafaxine (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 08 Dec 2021 Status changed from active, no longer recruiting to completed.
- 11 Mar 2021 Planned End Date changed from 1 Mar 2022 to 21 Apr 2022.
- 11 Mar 2021 Planned primary completion date changed from 1 Mar 2021 to 21 Apr 2021.